Prostanoid receptors: subtypes and signaling.

By R. Breyer, C. Bagdassarian, S. Myers, M. Breyer. Annual Review of Pharmacology and Toxicology, 2001

1,041 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Urinary bladder contraction and relaxation: physiology and pathophysiology. (2004, background): “In the relaxed smooth muscle cell, Rho is thought to be present in cytosol as Rho-GDP-GDI complexes, and activation in the presence of GTP is catalyzed by Rho-GEF and leads to a translocation of Rho to the cell membrane (237, 614).”
Eicosanoid actions in insect cellular immune functions (2006, background): “In mammalian systems, the physiological actions of most PGs are mediated by G protein-coupled receptors (GPCRs; Breyer et al., 2001).”
Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. (2004, neutral): “Commonly used selective EP receptor agonists include butaprost (EP2), sulprostone (EP3—also has low affinity for EP1 and FP), and PGE1-OH (EP4; Breyer et al., 2001).”
GPCR-I-TASSER: A hybrid approach to G protein-coupled receptor structure modeling and the application to the human genome (2015, background): “, 2012), Prostanoids (initiating cancer and inflammation pathways; Breyer et al., 2001), Releasing hormones (progression of cancers; Harrison et al.”